Pfizer delayed the announcement of its COVID-19 vaccine until after the 2020 election when it thought Donald Trump was defeated.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer's $25 support holds strong, with institutional buying signals and growth potential in oncology. Click here to read an ...

The ongoing investigation by Wyden and his Democratic compatriots from the Finance Committee has pointed the finger at ...

Senator Ron Wyden (D-Ore.), a senior member of the Senate Finance Committee, accused Pfizer (PFE) of carrying out what he ...

Sen. Ron Wyden and other Democrats claim Pfizer used a "colossal" scheme to avoid paying billions in U.S. taxes.

Pfizer (PFE) faces allegations from Senator Ron Wyden (D-Ore.) of running the largest tax-avoidance scheme in Big Pharma.

Pfizer Inc reported $0 in taxable U.S. profits on its 2019 tax returns, despite selling $20 billion in drugs to U.S. customers that year, Senate Finance Committee Democrats alleged in a new report ...

Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...

The inquiry is looking into a politically explosive suggestion that Pfizer delayed announcing a successful vaccine against ...

Pfizer (PFE) closed the most recent trading ... to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since ...